101 results
Page 3 of 6
8-K
ihn3t2f4dx
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-99.1
djrbxmbildjle
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am
424B5
tejdjlneehnfshc4z0
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
lag8qvk nhhgwyg
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
pm335lghv2n8p
10 Nov 21
Prospectus supplement for primary offering
5:25pm
424B5
ky3ya gqry
9 Nov 21
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
u3mnun72yjxu2r
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
8-K
EX-99.1
q34y8glt
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
8-K
EX-99.1
igh tzfr7zhe1co23
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
8-K
EX-99.1
mq9trjugak ur5
14 Aug 20
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
8:30am